对乙酰氨基酚过量后两袋与三袋乙酰半胱氨酸方案肝损伤发生率的比较
该回顾性队列研究比较了对乙酰氨基酚单次过量后8小时内接受乙酰半胱氨酸治疗的患者,两袋方案(200 mg/kg 4小时,100 mg/kg 16小时)与三袋方案(150 mg/kg 1小时,50 mg/kg 4小时,100 mg/kg 16小时)的急性肝损伤(ALI,定义为峰值转氨酶>150 IU/L)发生率。Monash Health 两袋组191例ALI发生率1.6%(3/191),三袋组180例为2.2%(4/180),差异-0.6%,p 0.7;加拿大CAOS数据库三袋组515例为2.9%(15/515),与两袋组差异-1.3%,p 0.4。肝毒性(ALT>1000)发生率分别为0.5%(1/191)、1.7%(3/180)和1%(5/515),组间均无统计学显著差异。作者认为两袋与三袋方案在早期给药下肝损伤发生率低且相当,治疗结束复查血检可识别需继续乙酰半胱氨酸的患者。
要点
- 对乙酰氨基酚过量后8小时内使用乙酰半胱氨酸,两袋方案ALI发生率1.6%(3/191),Monash三袋组2.2%(4/180),差异-0.6%(p 0.7)。
- 两袋方案与CAOS三袋组比较,ALI发生率1.6% vs 2.9%,差异-1.3%(p 0.4),无统计学显著差异。
- 肝毒性(ALT>1000)发生率:两袋组0.5%(1/191),Monash三袋组1.7%(3/180),CAOS三袋组1%(5/515)。
- 作者认为治疗结束时应复查血检,以识别发生ALI并需继续乙酰半胱氨酸的患者。
适用人群与场景
- 急性单次对乙酰氨基酚过量患者,就诊时转氨酶正常,且在过量后8小时内接受乙酰半胱氨酸治疗。
诊断标准与关键阈值
- 急性肝损伤(ALI)定义为峰值转氨酶>150 IU/L。
- 肝毒性定义为ALT>1000。
处置流程与药物剂量
- 两袋乙酰半胱氨酸方案:200 mg/kg 静脉输注4小时,随后100 mg/kg 输注16小时。
- 三袋乙酰半胱氨酸方案:150 mg/kg 静脉输注1小时,随后50 mg/kg 输注4小时,随后100 mg/kg 输注16小时。
- 作者认为应在乙酰半胱氨酸治疗结束时复查血液检查,以识别发生ALI并需继续乙酰半胱氨酸治疗的患者。
研究设计与关键结果
- 研究类型:回顾性队列研究,比较澳大利亚Monash Health(2009-2020)两袋与三袋乙酰半胱氨酸方案,并与加拿大Acetaminophen Overdose Study(CAOS)数据库(1980-2005)的三袋方案数据比较。
- 样本量:Monash Health两袋组191例,Monash Health三袋组180例,CAOS三袋组515例。
- 主要终点ALI发生率:两袋组1.6%(3/191),Monash三袋组2.2%(4/180),差异-0.6%(p 0.7);CAOS三袋组2.9%(15/515),与两袋组差异-1.3%(p 0.4)。
- 肝毒性(ALT>1000)发生率:两袋组0.5%(1/191),Monash三袋组1.7%(3/180),CAOS三袋组1%(5/515)。
- 组间各项比较均无统计学显著差异。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于急性单次对乙酰氨基酚过量、就诊时转氨酶正常且在8小时内开始乙酰半胱氨酸治疗的患者,两袋与三袋方案的急性肝损伤发生率低且无显著差异。
- 作者认为在乙酰半胱氨酸治疗结束时复查血液检查,可识别发生肝损伤并需要继续乙酰半胱氨酸治疗的患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Some studies have reported that early administration of acetylcysteine using a 3-bag regimen may not fully prevent development of liver injury in some patients. We compared the incidence of acute liver injury (ALI) in patients receiving acetylcysteine within eight hours of ingestion between the two-bag acetylcysteine regimen (200 mg/kg over four hours, 100 mg/kg over 16 h) and the three-bag regimen (150 mg/kg over 1 h, 50 mg/kg over 4 h, 100 mg/kg over 16 h).
METHOD: This was a retrospective cohort study of the two-bag and three-bag acetylcysteine regimens from Monash Health, Victoria, Australia (2009-2020), compared to the three-bag acetylcysteine regimen data from the Canadian Acetaminophen Overdose Study (CAOS) database (1980-2005). The inclusion criteria included patients with an acute single ingestion of paracetamol; normal aminotransferases on presentation and acetylcysteine administered within eight hours post-overdose. The primary outcome was development of ALI (defined as: peak aminotransferase >150 IU/L).
RESULTS: At Monash Health, 191 patients were treated with the two-bag acetylcysteine regimen, and 180 patients with the three-bag regimen. The CAOS cohort provided 515 patients treated with the three-bag regimen. ALI developed in 1.6% (3/191) of the two-bag Monash Health group, 2.2% (4/180) of the three-bag Monash Health group (difference -0.6%, p 0.7), and 2.9% (15/515) of the three-bag CAOS group (difference compared to two-bag -1.3%, p 0.4). Hepatotoxicity (ALT >1000) developed in 0.5% (1/191) of patients treated with the two-bag regimen, 1.7% (3/180) in the Monash Health three-bag regimen and 1% (5/515) of the three-bag CAOS group. There were no statistically significant differences between groups.
CONCLUSIONS: ALI and hepatotoxicity were observed in a small, comparable percentage of patients despite early acetylcysteine administration using the two-bag and three-bag regimens. Repeating blood tests at the end of acetylcysteine treatment will identify these patients and indicate those requiring continuation of acetylcysteine.
参考来源
- Syafira N, Graudins A, Yarema M, et al. Comparing development of liver injury using the two versus three bag acetylcysteine regimen despite early treatment in paracetamol overdose. Clin Toxicol (Phila). 2021. PMID: 34758680. doi:10.1080/15563650.2021.1998518
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。